Cite
HARVARD Citation
Marotta, A. et al. (n.d.). AB0944 Baseline serum 14-3-3 ETA levels predict ACR50 response to adalimumab therapy in psoriatic arthritis. Annals of the rheumatic diseases. p. 692. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Marotta, A. et al. (n.d.). AB0944 Baseline serum 14-3-3 ETA levels predict ACR50 response to adalimumab therapy in psoriatic arthritis. Annals of the rheumatic diseases. p. 692. [Online].